Nuvation Bio
NUVB
NUVB
154 hedge funds and large institutions have $429M invested in Nuvation Bio in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 36 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
4% less capital invested
Capital invested by funds: $447M → $429M (-$18.4M)
5.86% less ownership
Funds ownership: 61.92% → 56.07% (-5.9%)
99% less call options, than puts
Call options by funds: $7K | Put options by funds: $540K
Holders
154
Holding in Top 10
5
Calls
$7K
Puts
$540K
Top Buyers
| 1 | +$43.5M | |
| 2 | +$26.9M | |
| 3 | +$2.79M | |
| 4 |
Millennium Management
New York
|
+$2.14M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.75M |
Top Sellers
| 1 | -$3.94M | |
| 2 | -$3.74M | |
| 3 | -$1.91M | |
| 4 |
BC
BIT Capital
Berlin,
Germany
|
-$1.62M |
| 5 |
DM
Deerfield Management
New York
|
-$766K |